CONTRACT RESEARCH AND MANUFACTURING
Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…
There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring down the tariffs (raised recently) on a number of products. Two, it removes the fear hanging over some companies and sectors that they may be put on the tariff list if the situation is not resolved. Now, which is the sector where the fear of a possible tariff hike is most palpable? The answer is pharma. The reason it has not been tariffed by President Trump is that any additional duty will mean higher medicine costs in the US. And it will lead to higher inflation. But then you don't know what he might do. So, there is an element of “what if” at the moment, and getting that removed is good enough.
FDs fuel plastic dreams; PhysicsWallah revises DRHP
Happy Monday! Banks and fintechs launch low-limit secured credit cards to grow users. This and more in today's ETtech Morning Dispatch.
Indian semicon consortium bags deal for 5 lakh indigenous cameras
A nine-member Indian consortium led by Kaynes Semicon will supply over 500,000 fully indigenous dash and surveillance cameras by March 2026. With partners like NXP and CDAC, the project aims to localise over 50% of vision hardware by 2026, rising to 90% by 2030, reducing import dependence.
Dividend yield: Stock traders can use it differently to distinguish between the probability & possibility of making money
Dividend yield is not just an investor’s tool. At certain points in the market, it becomes just as relevant – sometimes even more so – for traders. Yes, traders. Now, why would dividend yield, of all things, act like a support line? The explanation lies in market memory and psychology. Around a certain level of dividend yield, value-oriented funds begin to step in because the price suddenly offers the comfort of an income stock. Momentum traders see valuation support and a floor building underneath the price. Options desks recalibrate, as downside looks limited and covered calls turn attractive. Each group is reacting to its own cues, but collectively they create the reflexive bounce that turns weakness into opportunity for traders.
PSU stocks: Time to relook? But don’t use the 2023 lens; choose the business. 57 PSU stocks, some good, some not so good
A bull run from June 2023 to June 2024, and then a bear run for a year. PSU stocks now seem at a stage where it is probably time to look at them again. For those who have not noticed, some of these stocks have seen higher-than-average volumes. Also a sort of outperformance in the bearish phase where they did not decline like other stocks in the market. They are not in the news any more; nor are many talking about them on TV. All signs suggesting it might probably be time to look at them again. But this time do it from a very different perspective – and not just because they are PSU. What matters is the category of business they fall into.
GST cut may lift drone sales, boost R&D, say startups
Founders of drone startups said the rate cuts will lower commercial drone prices by up to 10-15% for end users. They believe a lower GST will open new markets in defence, surveillance, and disaster management and help companies achieve quicker breakeven.
- Go To Page 1
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
In the last three trading sessions, the one thing clearly favouring the bulls was market breadth, especially in the mid-cap segment. A part of this optimism stems from the street’s expectation that the GST rate rationalisation will be implemented soon. Now, given that it may be implemented as soon as September 22, it probably takes away the fear that this festive season will suffer due to delayed purchases. So, in all probability, some select consumer stocks will get more attention in the coming days.
Multibagger or IBC - Part 22: Over Rs. 1,000 crore cash in books. Dry powder ready for EV play and M&As?
Internal combustion technologies face long-term disruption as EV adoption grows, but this auto ancillary player is hedging its bets. While the core business continues to support a deep OEM client base, the company has stepped into electric mobility with motors and controllers. The latest financials show growing revenues, healthy margins and EPS, and strong cash reserves. Diversification across 45+ countries, steady dividend payouts, and disciplined capital allocation provide resilience, making this company’s transition worth tracking in the fast-changing auto ancillary landscape. This series on auto ancillary companies works with the assumption that, from the whole set of auto ancillary companies, some multibagger stocks will emerge. And some companies in this space risk going bankrupt.
Sensex rises 410 pts, Nifty50 tops 24,700 as banks, metal stocks advance
Indian markets closed higher on Wednesday, driven by banking and metal stocks, as investors anticipated GST Council updates regarding potential rate cuts. The Nifty rose by 0.55%, and the Sensex increased by 0.51%. Metal stocks surged, led by Tata Steel, while the IT index lagged due to concerns over U.S. manufacturing data.
Treasury chaos: 30-year yield soars past 4.97% as US faces tariff refund threat
Treasury yields moved higher as investors worried about the future of U.S. tariffs after a key court ruling. The 30-year yield crossed 4.97%, its highest in weeks, while global bond markets also saw a sharp rise. The case over Trump tariffs has now created fresh questions for Wall Street, government revenue, and market stability.
Commodity Radar: MCX copper contracts offer buy on dips opportunity despite weak chart structure. Here’s why
Copper prices on MCX rose 0.6% to Rs 902.85 despite global weakness, supported by rupee depreciation. Analysts see bullish short-term momentum above Rs 900, with potential upside towards Rs 927, though weak indicators suggest caution in sustainability.
Dividend yield: There is more to it than meets the eye, both for investors & traders, especially in volatile times. 11 stocks to look at
These days the Nifty and Sensex tend to slip into volatility every second week. Given the tariff situation, we don't know for how long this will continue. To deal with volatility, it would be a good idea to use a mix of conventional and unconventional methods. This will ensure that, if the market stays under pressure and stocks do not create wealth, they at least generate income. Now, what is the income stocks generate? It is the dividend you get by holding a stock. It is different from income which trading in stocks generates. So, don't confuse the two. Dividend yield can help both investors and traders. In the case of traders, it will require some hard work. But who said making money in the market is easy?
Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%
Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declined after the imposition of two rounds of tariffs, with the latest of 25% kicking in on August 27, pharma stocks have also seen drops over the past month. Now, is this an opportunity, given that the sector is exempt? Perhaps. Because, one does not know what President Trump may do in the future. But the pharma sector merits a closer look for reasons other than being exempt from tariffs. For, in the last 20 years, companies in this sector, because of some inherent advantages, have been able to deliver. And going forward, there is a high probability that these tailwinds will increase.
Are you taking a common heart attack pill? It might not help you, study says
Two large trials offer conflicting evidence on the benefits of beta-blockers for heart attack patients with normal heart function. While one study showed no effect, another indicated a reduced risk of adverse cardiovascular events. Both trials agreed that beta-blockers benefit patients with mildly impaired heart function, prompting further investigation into their efficacy for those with healthy hearts.
Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 30% in 1 year
There is high probability that we will see more volatility in the coming days. While it is not always the case, sometimes the expiry of a derivative series contract throws light on what might happen in the near term. This time around, it has indicated continued volatility. The task for investors is therefore to reframe volatility not as a threat but as an entry point. Buying into weakness requires patience and conviction, but history tells us that those who take the longer view are rewarded. It means ignoring the noise and focusing on whether the company’s competitive edge, innovation pipeline, or consumer franchise will still matter five or ten years from now. Our selected stocks for today depict a strong upward trajectory in their overall average score which is based on five key pillars: Earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
American PSUs: New asset class? Intel is done, Lockheed Martin is in the air. Who might be next on Trump's American PSU dream list? And why?
For over two centuries, the US has distinguished itself from state-led economies by keeping government ownership out of private enterprise. Washington regulated, subsidised, and contracted. But it never owned. That firewall is now showing cracks. The Trump administration’s purchase of a nearly 10% stake in Intel, with hints of similar moves in defence giants like Boeing and Lockheed Martin, signals a profound shift. Is America inching toward its own PSU model? Or is it laying the groundwork for its version of a sovereign wealth fund? Either way, it marks a turning point in the story of American capitalism and how valuations would be done across global markets.
IIP hits 4-month high in July
India's industrial output surged to a four-month high of 3.5% in July, fueled by a robust manufacturing sector that grew at a six-month high. Infrastructure and construction goods saw significant expansion, indicating strong public sector capital expenditure.
A forward-looking defence acquisition policy can unlock foreign tech transfer and investments
India is set to collaborate with France's Safran for indigenous jet engine development, aligning with the nation's self-reliance push in defense. A review of the Defence Acquisition Procedure 2020 is underway to address inefficiencies and attract foreign technology transfer. Policy shifts aim to boost local manufacturing and exports, but stakeholder interests and FDI inflows remain key challenges.
These large- and mid-cap stocks can give more than 24% return in 1 year, according to analysts
As some sectors and industries start to feel the impact of the increased tariffs, the chances are that, in the near term, all the street narrative will centre on this. But make a distinction between reality and narrative. We are not saying that there will be no impact. But the fact is that some amount of exaggeration is to be expected as an industry seeks favours from the government and hopes to extract some relief. So, remain balanced when consuming information. Just to put this in perspective: Does it make sense to sell HDFC Bank because of the tariff? Certainly not. So think rationally before taking any decision.
For ‘some’ investors, a crisis is an opportunity: 5 large-caps from different sectors with an upside potential of up to to 32%
Here’s what you will now often hear on the street: With the additional 25% Trump tariff kicking in, we are in unprecedented times; job losses, unemployment have risen in some sectors. There is and will be no dearth of lobbyists who will plant the news here and there. Now, when was the last time you heard something like this? When there was tension on the border with Pakistan? When Israel bombed Iran? When the Adani-Hindenburg crisis erupted? When the Russia-Ukraine war started? Every crisis seems the gravest ever when it erupts, but all these events are mere blips when we look back. So, ignore all the panic and focus on the long term. Remember that good businesses have grown and flourished through all the above-mentioned crises.
Will they finally get the chemistry right? 9 stocks from the specialty chemicals space with an upside potential of up to 45%
While they come under the broad “chemicals sector” umbrella, each specialty chemicals company is literally an industry in itself. Each has its own operating matrix, supply chain, and demand. Just to put this in perspective: Fluorochemicals & fluoropolymers are currently facing overcapacity, but others are in a shortage situation because China hit a pause on exports. For some companies, trouble in China means a big bonus; for others, it means supply chain issues affecting production in India. The Chinese companies themselves have gone through many ups and downs in the past three years. From increasing capacity to cater to the EV boom to pricing wars as they tried to muscle into Europe. All this had its impact on India. We are not saying that things have changed, but Indian companies have learnt to live with increased competition. And that is a good enough reason to revisit these stocks.
China is pouring exports into Africa faster than anywhere else
China is also opening its markets to African goods and offering financial support, potentially increasing the yuan's influence.
Bhagwati Products eyes over two-fold surge in FY26 revenue
Bhagwati Products, in partnership with Huaqin, aims to more than double its revenue to Rs 15,000 crore by FY26, driven by expanded manufacturing of Android devices and exports. The company is building new factories and investing in R&D to shift towards original product design, leveraging Huaqin's global customer base and creating original designs for mixed-reality glasses.
Wealth creation has another name: Ignore noise & Trump. Just hold on to good businesses; 22 stocks from different sectors that fit the bill
With the additional 25% tariff all but a reality, here's a question: What will President Trump say or do next? Can anyone predict that? The answer is no. So, if you cannot predict what the man responsible for all the recent market turmoil will do, why try to predict what will happen to stock prices? At such a juncture, you will do well to remember that while the markets are about buying and selling, there is a third option. Which is hold. And when it comes to wealth creation, there are times when it is more important to just hold on to stocks. So if you have quality stocks, stop analysing what is happening to the Nifty and Sensex every day.
Lower GST will re-energise agri and rural sectors: Ashi Anand
Ashi Anand suggests a GST cut on farm equipment could boost India's rural economy. He believes large-scale tariffs on medicines are unlikely, despite US policy unpredictability. Investors should be selective in pharma, focusing on biosimilars and CRAMS. GLP therapies present a major opportunity as patents expire. CDMOs and branded generic players are well-positioned to capitalize on this trend.
Sai Life Sciences shares drop 4% as TPG Asia likely offloads Rs 2,811 cr worth shares via block deal
Sai Life Sciences' shares experienced a 4% drop following a significant trade involving 3.2 crore shares. TPG Asia likely divested a 15.4% stake in the company through a block deal at Rs 874 per share, potentially marking a complete exit for the private equity firm.
Cohance Lifesciences and other pharma stocks jump up to 5% after Jefferies initiates Buy recommendation
Cohance Lifesciences, Divi’s Laboratories, and SAI Life Sciences rallied after Jefferies initiated coverage with ‘Buy’ ratings, citing strong growth prospects in India’s CRDMO sector. The brokerage sees a high-teen revenue CAGR, led by China+1 diversification, pipeline visibility, and demand for diabetes and weight-loss therapies.
Battery startup Lyten yet to convince carmakers over Northvolt revival
Silicon Valley’s Lyten has acquired bankrupt Northvolt’s assets to build a European EV battery champion. It aims to scale lithium-sulfur technology but faces scepticism, funding challenges, and stiff competition. Customers and investors burned by the Northvolt experience remain wary of committing without seeing a proven product that can be delivered at scale, interviews with over a dozen battery industry experts, analysts and car company sources revealed.
Market Wrap: Sensex rises 142 points, Nifty tops 25,050 in 6-day winning streak amid GST reform optimism
Indian benchmark indices Sensex and Nifty advanced on Thursday, extending their rally to a sixth straight session as optimism over a potential cut in Goods and Services Tax (GST), strength in financials from a proposal to exempt insurance premiums from tax, and gains in Reliance Industries lifted the market.
Load More
